Joe Putnam
Faculty Member
Last active: 3/27/2014

Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.

Grogan EL, Deppen SA, Ballman KV, Andrade GM, Verdial FC, Aldrich MC, Chen CL, Decker PA, Harpole DH, Cerfolio RJ, Keenan RJ, Jones DR, D'Amico TA, Shrager JB, Meyers BF, Putnam JB
Ann Thorac Surg. 2014 97 (4): 1142-8

PMID: 24576597 · PMCID: PMC4008142 · DOI:10.1016/j.athoracsur.2013.12.043

MeSH Terms (15)

Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung Female Fluorodeoxyglucose F18 Humans Lung Neoplasms Male Middle Aged Neoplasm Staging Positron-Emission Tomography Prospective Studies Radiopharmaceuticals Reproducibility of Results

Connections (3)

This publication is referenced by other Labnodes entities: